Layer-2Melior Discovery Logo

Capture the Untapped Value of Therapeutics

  • Right Side Logo
  • About Us
    • About Us
    • Partner with Us
    • Management Team
    • Scientific Advisors
    • FAQs
    • Careers
  • In Vivo Pharmacology Platforms
    • theraTRACE®
    • opioidTRACE®
    • Immuno-theraTRACE®
  • In Vivo Disease Models
  • Insights and Discoveries
    • Press Releases
    • Melior Insights
    • Case Studies
    • Melior Publications
    • Collaborative Discoveries
    • Articles of Interest
    • Client Success
  • Contact
Insights and DiscoveriesPress Releases

    Melior Discovery Press

    Home Press Releases
    • Insights and Discoveries
      • Press Releases
      • Melior Insights
      • Case Studies
      • Melior Publications
      • Collaborative Discoveries
      • Articles of Interest
      • Client Success

    Ready to get started?

    Contact us today to speak to a scientist about your project

    Contact Us
     Press Releases
    Discovery Image

    Press Release

    Melior Discovery Selected as Preclinical CRO to Support Linnaeus Therapeutics’ ARPA-H PROSPR Program

    July 21, 2026

    Download PDF

    Discovery Image

    Press Release

    Melior is Recognized as CRO of the Year by Life Sciences Review

    March 19, 2024

    Download PDF

    Discovery Image

    Press Release

    Melior is Selected as a TOP 20 CRO by Pharma Tech Outlook

    June 22, 2023

    Download PDF

    Discovery Image

    Press Release

    Melior Announces Substantial Additions to its Management and Scientific Team

    April 12, 2022

    Download PDF

    Discovery Image

    Press Release

    Melior Pharmaceuticals Completes Licensing Agreement with Adhera Therapeutics for Armesocarb

    July 29, 2021

    Download PDF

    Discovery Image

    Press Release

    Melior Pharmaceuticals Enters Into Letter-of-Intent for Sale of Armesocarb

    June 7, 2021

    Download PDF

    Discovery Image

    Press Release

    Melior Pharmaceuticals Receives IND Clearance from US FDA for COVID-19 Therapeutic

    March 9, 2021

    Download PDF

    Discovery Image

    Press Release

    Melior Pharmaceuticals Announces Grant Award for Initiating COVID-19 Clinical Trial

    September 15, 2020

    Download PDF

    Discovery Image

    Press Release

    Melior Discovery Announces Partnership with SFA on Grant Directed to COVID-19

    June 24, 2020

    Download PDF

    Melior Discovery is DEA-licensed for Schedule I-V

    Capture the Untapped Value of Therapeutics

    Our Company

    • About Us
    • Management Team
    • Scientific Advisors
    • FAQs
    • Careers

    What We Do

    • In Vivo Pharmacology Platforms
    • theraTRACE®
    • opioidTRACE®
    • Efficacy Models

    Resources

    • Press Releases
    • Melior Publications
    • Collaborative Discoveries
    • Articles of Interest

    Get Started

    • Partner with us
    • Contact
    © 2005-2026 MELIOR DISCOVERY | ALL RIGHTS RESERVED | P 610.280.0633 | EXTON, PA | SITE MAP | Legal Notices | Privacy Policy
    Affliated With